2008 Aug 18;26(35):4417-9. Epub 2008 Jul 3. Abstract We present a 19-year-old girl who developed a left brachial plexus neuritis following vaccination with a quadrivalent human papillomavirus (HPV) vaccine. Post-vaccination brachial plexus neuritis is a rare event. Nevertheless, this first case warrants careful attention in view of the large vaccination campaigns in young adolescents being […]
A 16-Year-Old Girl With Bilateral Visual Loss and Left Hemiparesis Following an Immunization Against Human Papilloma Virus.
J Child Neurol March 2010 vol. 25 no. 3 321-327 Francis J. DiMario Jr, MD, et al We report the course of a 16-year-old girl who presented with near complete visual loss associated with chiasmal neuritis and a biopsy proven tumefactive demyelinating lesion on magnetic resonance imaging (MRI) in association with a recent immunization against […]
The Risks and Benefits of HPV Vaccination
Charlotte Haug, MD, PhD, MSc JAMA. 2009;302(7):795-796. When do physicians know enough about the beneficial effectsof a new medical intervention to start recommending or usingit? When is the available information about harmful adverseeffects sufficient to conclude that the risks outweigh the potentialbenefits? If in doubt, should physicians err on the side ofcaution or on the side […]
Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine.
JAMA. 2009 Aug 19;302(7):750-7. Abstract CONTEXT: In June 2006, the Food and Drug Administration licensed the quadrivalent human papillomavirus (types 6, 11, 16, and 18) recombinant vaccine (qHPV) in the United States for use in females aged 9 to 26 years; the Advisory Committee on Immunization Practices then recommended qHPV for routine vaccination of […]
Reports of Autoimmune Disorders After HPV Vaccine Raise Questions
From Medscape Medical News September 23, 2009 (Düsseldorf, Germany) — Investigators have identified cases of autoimmune disorders after immunization with the quadrivalent vaccine Gardasil. The Merck product is designed to prevent infection with several types of human papillomavirus. Presenting here at the 25th Congress of the European Committee for Treatment and Research in Multiple […]
- « Previous Page
- 1
- …
- 87
- 88
- 89
- 90
- 91
- …
- 94
- Next Page »